Axa
BRLI

Axa’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Axa’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-50,700
Closed -$2.09M – 1559
2015
Q2 		$2.09M Buy
50,700
+20,500
+68% +$735K 0.01% 781
2015
Q1 		$1.06M Buy
30,200
+6,200
+26% +$210K ﹤0.01% 929
2014
Q4 		$771K Buy
+24,000
New +$694K ﹤0.01% 1023

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Axa's BRLI Position: Q3 2015 in Review

Axa sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 50,700 shares — an estimated $2.09M sold.

Axa first reported a position in BRLI in Q4 2014 and held it in 3 quarters. The position peaked at $2.09M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Axa reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Axa sold 50,700 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $2.09M.
  • Axa first reported a position in BIO-REFERENCE LABS INC-NEW- in Q4 2014 and held it in 3 quarters.
  • Axa's BIO-REFERENCE LABS INC-NEW- position peaked at $2.09M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Axa's 13F filing for Q3 2015, filed 13 Nov 2015.